Wellington Management Company »

Adma Biologics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $967k 214k 4.52

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Adma Biologics

Vanguard Group
D. E. Shaw & Co
Perceptive Advisors
AWM Investment Company
Dimensional Fund Advisors
Millennium Management
Assenagon Asset Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Oberweis Asset Management
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Tang Capital Management

View all funds holding Adma Biologics